Skip to the page

Data / Form D filings / Med Aditus Pharmaceuticals, Inc.

Med Aditus Pharmaceuticals, Inc.: Form D filing

Med Aditus Pharmaceuticals, Inc., a pharmaceuticals company in Rtp, NC, filed a Form D with the SEC in 2024. The latest, on November 6, 2024, reports an offering of $5 million with nothing sold yet.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
800 Park Offices Drive, Suite 3604, Rtp, NC, 27709
Phone
(919) 606-6688
Industry
Pharmaceuticals
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2023
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2041640

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Nov 6, 2024New notice$5,000,000$0$5,000,0000Yet to occursec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
David R. StefanichDirector
Kay P. WagonerDirector
Khama R. RogoDirector
Mary P. GunnDirector
Dhiren R. ThakkerExecutive Officer, Director

Other pharmaceuticals companies in North Carolina that filed recently

Every Form D from the week of Nov 4, 2024 · All recent filings in North Carolina · All recent Pharmaceuticals filings

Read from SEC EDGAR. Amount sold is what Med Aditus Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.